In The Press July 11, 2018

INSIGHTS - The Ongoing Debate About Disclosing Manufacturing Process Information in the Patent Dance (Bloomberg BNA)

Partner Keith Zullow discusses how disputes often arise regarding what is required of a biosimilar applicant to comply with subsection (l)(2)(A) of the BPCIA, a provision that kicks off the patent dance. Although this issue arises frequently in litigation, it is unclear whether courts will ever resolve it.

Read the full article here.